New Targeted Therapies in Myelodysplastic Syndrome: the Role of Farnesyltransferase and Proteasome Inhibitors
AuthID
P-00J-0FD
P-00J-0FD
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service